Company / Gross Profit
IRADIMED CORP Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$64.3M
FY2025
5-year range
$29.7M / $64.3M
FY2021-FY2025
Trend
+14.2%
vs FY2024
Sector context
#95 of 100
Health Care
What the data says
Among 100 Health Care companies, IRADIMED CORP is in the bottom 5% for gross profit. Gross Profit has increased for 5 consecutive years, from $24M in FY2020 to $64M in FY2025.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +22.2%.
Improved from $50M to $64M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 100This company $64.3M Sector average $1.8B
▼
-96.5% below sector average
Key checks
Key Insights
- IRADIMED CORP's gross profit has grown for 5 consecutive years.
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, gross profit increased 14.2% year-over-year.
- Ranks #95 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.3M | +14.2% |
| FY2024 | $56.4M | +12.3% |
| FY2023 | $50.2M | +56.5% |
| FY2022 | $32.0M | +7.9% |
| FY2021 | $29.7M | +26.0% |
| FY2020 | $23.6M | -20.6% |
| FY2019 | $29.7M | +12.8% |
| FY2018 | $26.3M | +2.3% |
| FY2017 | $25.8M | +110.3% |
| FY2016 | $12.2M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026